Skip to main content
. 2021 Jan 12;151(3):649–656. doi: 10.1093/jn/nxaa371

TABLE 1.

Characteristics of women by categories of weight change since 18 y in the EARTH Study1

Weight change since 18 y (kg)
Characteristic <0 0–4.9 5–9.9 10–14.9 ≥15 P value2
Median weight change, kg −3.1 2.5 7.4 12.3 22.0
Number of women 58 129 117 75 107
Personal characteristics
 Current age, y 34.7 ± 3.7 35.0 ± 4.0 35.1 ± 4.1 36.3 ± 3.7 36.2 ± 4.4 0.01
 Height, cm 163.7 ± 5.9 164.9 ± 6.7 165.4 ± 6.5 164.6 ± 7.1 166.6 ± 6.8 0.09
 BMI at 18 y, kg/m2 22.5 ± 2.4 20.8 ± 2.1 20.2 ± 2.6 20.6 ± 3.7 21.2 ± 2.9 <0.001
 Current BMI, kg/m2 21.0 ± 2.1 21.8 ± 2.1 23.0 ± 2.7 25.2 ± 4.0 29.8 ± 4.2 <0.001
 Years since 18 y 16.7 ± 3.7 17.0 ± 4.0 17.1 ± 4.1 18.3 ± 3.7 18.2 ± 4.4 0.01
 Ever smoker 13 (22.4) 32 (24.8) 34 (29.1) 18 (24.0) 30 (28.0) 0.84
 White 49 (84.5) 108 (83.7) 96 (82.1) 60 (80.0) 86 (80.4) 0.93
 Education <0.001
  <College 1 (1.7) 4 (3.1) 4 (3.4) 7 (9.3) 16 (15.0)
  College degree 23 (39.7) 39 (30.2) 55 (47.0) 29 (38.7) 45 (42.1)
  Graduate degree 34 (58.6) 86 (66.7) 58 (49.6) 39 (52.0) 46 (43.0)
Cycle characteristics
 Parous 6 (10.3) 12 (9.3) 17 (14.5) 10 (13.3) 17 (15.9) 0.56
 Previous IUI 26 (44.8) 35 (27.1) 40 (34.2) 29 (38.7) 38 (35.5) 0.17
 Previous IVF 9 (15.5) 19 (14.7) 24 (20.5) 20 (26.7) 26 (24.3) 0.18
 Primary infertility diagnosis 0.67
  Male factor 17 (29.3) 34 (26.4) 36 (30.8) 28 (37.3) 34 (31.8)
  Female factor 15 (25.9) 41 (31.8) 35 (29.9) 20 (26.7) 38 (35.5)
   Diminished ovarian reserve 5 (8.6) 15 (11.6) 14 (12.0) 5 (6.7) 10 (9.4)
   Endometriosis 1 (1.7) 6 (4.7) 7 (6.0) 3 (4.0) 10 (9.4)
   Ovulation disorders 8 (13.8) 7 (5.4) 7 (6.0) 6 (8.0) 7 (6.5)
   Tubal factor 1 (1.7) 11 (8.5) 5 (4.3) 5 (6.7) 9 (8.4)
   Uterine disorders 0 (0.0) 2 (1.6) 2 (1.7) 1 (1.3) 2 (1.9)
  Unexplained 26 (44.8) 54 (41.9) 46 (39.3) 27 (36.0) 35 (32.7)
 PCOS 5 (8.6) 12 (9.3) 10 (8.6) 6 (8.0) 17 (15.9) 0.31
 Treatment protocol 0.42
  Antagonist 8 (13.8) 15 (11.6) 19 (16.2) 10 (13.3) 14 (13.1)
  Flare 2 (3.5) 14 (10.9) 14 (12.0) 10 (13.3) 20 (18.7)
  Luteal phase agonist 44 (75.9) 88 (68.2) 74 (63.3) 51 (68.0) 62 (57.9)
  Egg donor or cryo 4 (6.9) 12 (9.3) 10 (8.6) 4 (5.3) 11 (10.3)
 Day 3 FSH, IU/L 7.3 ± 2.1 7.6 ± 3.5 7.5 ± 2.6 7.0 ± 1.7 7.5 ± 2.5 0.93
 Embryo transfer day3 0.62
  Day 2 3 (6.8) 8 (7.8) 4 (4.2) 2 (3.1) 6 (7.2)
  Day 3 18 (40.9) 53 (51.5) 43 (45.3) 36 (55.4) 44 (53.0)
  Day 5 23 (52.3) 42 (40.8) 48 (50.5) 27 (41.5) 33 (39.8)
 Number of embryos transferred3 0.40
  1 embryo 11 (25.6) 30 (29.1) 21 (22.1) 14 (21.5) 22 (26.5)
  2 embryos 27 (62.8) 58 (56.3) 56 (59.0) 36 (55.4) 39 (47.0)
  ≥3 embryos 5 (11.6) 15 (14.6) 18 (19.0) 15 (23.1) 22 (26.5)

1Values are number (%) of women or means ± SDs unless otherwise indicated. FSH, follicle stimulation hormone; IUI, intrauterine insemination; IVF, in vitro fertilization; PCOS, polycystic ovarian syndrome.

2From Kruskal-Wallis test for continuous variables and χ2 tests or Fisher exact tests (when 1 or more cell counts were ≤5) for categorical variables.

3Embryo transfer day and number were assessed only among fresh cycles with embryo transfer.